연구성과로 돌아가기
JCR 2024 저널 목록 (959 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JOURNAL OF CELL SCIENCE | COMPANY BIOLOGISTS LTD | 0021-9533 | 1477-9137 | SCIE | CELL BIOLOGY | 36,688 | 3.6 | Q2 | 48.8 | 51.2 | 100/204 | 3.8 | Q3 | 3.4 | 1.1 | 0.54 | 127/204 | Q3 | 37.99 | 0.020 | 4.491 | 1.488 | Q2 | 249 | 89.6% | 13.0 | 10.1 | 223 | 44.2% | 2025-08-05 16:02:38 | 바로가기 |
| Magnetochemistry | MDPI | N/A | 2312-7481 | SCIE | CHEMISTRY, INORGANIC & NUCLEAR | 2,155 | 2.5 | Q2 | 48.8 | 51.2 | 21/42 | 2.6 | Q2 | 2.3 | 0.4 | 0.45 | 32/43 | Q3 | 26.74 | 0.002 | 0.482 | 0.387 | Q2 | 100 | 90.0% | 3.0 | 7.8 | 90 | 100.0% | 2025-08-05 16:02:39 | 바로가기 |
| MOLECULAR AND CELLULAR ENDOCRINOLOGY | ELSEVIER IRELAND LTD | 0303-7207 | 1872-8057 | SCIE | CELL BIOLOGY | 15,716 | 3.6 | Q2 | 48.8 | 51.2 | 100/204 | 3.8 | Q3 | 3.5 | 0.6 | 0.80 | 84/204 | Q2 | 59.07 | 0.008 | 1.821 | 0.933 | Q3 | 171 | 99.4% | 9.7 | 9.2 | 170 | 18.4% | 2025-08-05 16:02:38 | 바로가기 |
| New Zealand Geographer | WILEY | 0028-8144 | 1745-7939 | SSCI | GEOGRAPHY | 359 | 1.2 | Q2 | 48.8 | 51.2 | 85/173 | 1.4 | Q3 | 1.1 | 0.9 | 0.56 | 80/173 | Q2 | 54.05 | 0.000 | 0.066 | 0.430 | Q2 | 16 | 100.0% | 9.6 | 8.5 | 16 | 80.8% | 2025-08-05 16:03:21 | 바로가기 |
| Space and Culture | SAGE PUBLICATIONS INC | 1206-3312 | 1552-8308 | SSCI | GEOGRAPHY | 868 | 1.2 | Q2 | 48.8 | 51.2 | 85/173 | 1.1 | Q3 | 1.2 | 0.4 | 0.86 | 41/173 | Q1 | 76.59 | 0.001 | 0.208 | 0.420 | Q2 | 14 | 100.0% | 9.3 | 12.6 | 14 | 30.2% | 2025-08-05 16:03:21 | 바로가기 |
| STEM CELLS | OXFORD UNIV PRESS | 1066-5099 | 1549-4918 | SCIE | CELL BIOLOGY | 15,176 | 3.6 | Q2 | 48.8 | 51.2 | 100/204 | 4.4 | Q2 | 3.5 | 0.7 | 0.84 | 76/204 | Q2 | 62.99 | 0.005 | 1.219 | 1.171 | Q2 | 74 | 82.4% | 11.0 | 7.3 | 61 | 28.3% | 2025-08-05 16:02:38 | 바로가기 |
| World Journal of Stem Cells | BAISHIDENG PUBLISHING GROUP INC | 1948-0210 | 1948-0210 | SCIE | CELL BIOLOGY | 2,755 | 3.6 | Q2 | 48.8 | 51.2 | 100/204 | 4.4 | Q2 | 3.3 | 1.6 | 0.53 | 132/204 | Q3 | 35.54 | 0.003 | 0.602 | 0.839 | Q3 | 61 | 73.8% | 4.7 | 5.8 | 45 | 86.3% | 2025-08-05 16:02:38 | 바로가기 |
| Asian Business & Management | PALGRAVE MACMILLAN LTD | 1472-4782 | 1476-9328 | SSCI | MANAGEMENT | 908 | 2.8 | Q2 | 48.9 | 51.1 | 206/420 | 3.2 | Q3 | 2.5 | 1.3 | 0.50 | 261/421 | Q3 | 38.12 | 0.001 | 0.169 | 0.516 | Q3 | 23 | 91.3% | 4.5 | 10.2 | 21 | 13.8% | 2025-08-05 16:03:52 | 바로가기 |
| Cancer Pathogenesis and Therapy | ELSEVIER | 2097-2563 | 2949-7132 | ESCI | ONCOLOGY | 138 | 2.8 | Q2 | 48.9 | 51.1 | 160/326 | 2.8 | Q3 | 2.7 | 1.5 | 0.52 | 205/326 | Q3 | 37.27 | 0.000 | 0.036 | 0.614 | Q3 | 31 | 64.5% | 1.2 | 5.6 | 20 | 100.0% | 2025-08-05 16:04:25 | 바로가기 |
| Clinical Child Psychology and Psychiatry | SAGE PUBLICATIONS INC | 1359-1045 | 1461-7021 | SCIE | PSYCHOLOGY | 2,199 | 2.0 | Q2 | 48.9 | 51.1 | 46/93 | 2.2 | Q3 | 2.0 | 0.4 | 0.53 | 60/93 | Q3 | 36.02 | 0.003 | 0.601 | 0.675 | Q3 | 54 | 94.4% | 5.9 | 8.4 | 51 | 24.8% | 2025-08-05 16:04:57 | 바로가기 |
| Cogent Business & Management | TAYLOR & FRANCIS LTD | 2331-1975 | 2331-1975 | ESCI | BUSINESS | 6,969 | 2.9 | Q2 | 48.9 | 51.1 | 155/316 | 3.3 | Q3 | 2.4 | 0.8 | 0.65 | 148/317 | Q2 | 53.47 | 0.005 | 1.034 | 0.362 | Q3 | 846 | 87.4% | 2.9 | 6.5 | 739 | 98.4% | 2025-08-05 16:02:35 | 바로가기 |
| CORROSION REVIEWS | WALTER DE GRUYTER GMBH | 0334-6005 | 2191-0316 | SCIE | ELECTROCHEMISTRY | 1,666 | 3.2 | Q2 | 48.9 | 51.1 | 22/44 | 4.2 | Q2 | 3.0 | 0.6 | 0.35 | 30/44 | Q3 | 32.95 | 0.001 | 0.229 | 0.655 | Q2 | 66 | 59.1% | 5.8 | 8.2 | 39 | 4.0% | 2025-08-05 16:03:02 | 바로가기 |
| European Journal of Training and Development | EMERALD GROUP PUBLISHING LTD | 2046-9012 | 2046-9020 | ESCI | MANAGEMENT | 1,470 | 2.8 | Q2 | 48.9 | 51.1 | 206/420 | 3.2 | Q3 | 2.5 | 0.1 | 0.54 | 255/421 | Q3 | 39.55 | 0.001 | 0.289 | 0.560 | Q3 | 40 | 90.0% | 4.8 | 7.9 | 36 | 9.6% | 2025-08-05 16:03:52 | 바로가기 |
| European Management Review | WILEY PERIODICALS, INC | 1740-4754 | 1740-4762 | SSCI | MANAGEMENT | 1,908 | 2.8 | Q2 | 48.9 | 51.1 | 206/420 | 3.7 | Q2 | 2.6 | 0.3 | 0.72 | 191/421 | Q2 | 54.75 | 0.002 | 0.437 | 0.782 | Q2 | 65 | 93.8% | 5.1 | 12.5 | 61 | 56.1% | 2025-08-05 16:03:52 | 바로가기 |
| Expert Review of Anticancer Therapy | TAYLOR & FRANCIS LTD | 1473-7140 | 1744-8328 | SCIE | ONCOLOGY | 4,123 | 2.8 | Q2 | 48.9 | 51.1 | 160/326 | 2.9 | Q3 | 2.8 | 0.5 | 0.51 | 210/326 | Q3 | 35.74 | 0.003 | 0.705 | 0.762 | Q3 | 103 | 29.1% | 6.8 | 5.3 | 30 | 12.6% | 2025-08-05 16:04:24 | 바로가기 |
페이지 이동: